Images Powered by Shutterstock
Recurrent Bladder Cancer in a Teenage Male

Recurrent Bladder Cancer in a Teenage Male

Recurrent Bladder Cancer in a Teenage Male - Beyond the Abstract June 1, 2020 There is a growing population of pediatric, adolescent, and young adult patients with urologic...

Role of Blue Light Cystoscopy in Bladder Cancer Management - Trinity Bivalacqua

Role of Blue Light Cystoscopy in Bladder Cancer Management - Trinity Bivalacqua

Trinity Bivalacqua joins Ashish Kamat to discuss the role of blue light cystoscopy in bladder cancer treatment, specifically regarding non-muscle invasive disease. Dr....

Low-Intensity Surveillance Is Beneficial for High-Risk NMIBC

Low-Intensity Surveillance Is Beneficial for High-Risk NMIBC

Low-intensity surveillance may be comparable to high-intensity surveillance for cancer control in patients with high-risk non-muscle invasive bladder cancer (NMIBC). Results...

Immunotherapy improves survival in patients with advanced bladder cancer

Immunotherapy improves survival in patients with advanced bladder cancer

An immunotherapy drug 'avelumab' significantly improves survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial...

Some patients with bladder cancer 'can't wait' for treatment during the COVID-19 pandemic

Some patients with bladder cancer 'can't wait' for treatment during the COVID-19 pandemic

Bladder cancer is associated with significant illness and mortality, particularly if treatment is delayed. Writing in the journal Bladder Cancer, researchers have outlined...

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes Tumour heterogeneity Abstract Histological and molecular analyses of urothelial...

Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer

Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer

Bladder Cancer SHARE Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer - Beyond the Abstract May 5, 2020 Although...

Kidney Cancer Signs, Symptoms, Causes, Treatments

Kidney Cancer Signs, Symptoms, Causes, Treatments

Let’s start with the basics. Your kidneys are two potato-shaped organs that sit behind your belly on either side of the spine. They filter your blood—straining out salt, water,...

Neoadjuvant Nivolumab/Chemotherapy Safe and Effective in Muscle-Invasive Bladder Cancer

Neoadjuvant Nivolumab/Chemotherapy Safe and Effective in Muscle-Invasive Bladder Cancer

Nivolumab (Opdivo) in combination with gemcitabine and cisplatin in the neoadjuvant setting led to a pathologic nonmuscle-invasive rate of 66% and a pathologic complete response...

TERT Promoter Mutations Detectable 10 Years Prior to Bladder Cancer Diagnosis

TERT Promoter Mutations Detectable 10 Years Prior to Bladder Cancer Diagnosis

A study published in EBioMedicine provides the first evidence from a population-based prospective cohort study of the potential of urinary telomerase reverse transcriptase...

Diagnosing and Monitoring Bladder Cancer – Bladder Cancer Advocacy Network

Diagnosing and Monitoring Bladder Cancer – Bladder Cancer Advocacy Network

Banner Image: Dr. Neal Shore, a member of the BCAN Board of Directors, speaks with a patient about diagnosing and monitoring bladder cancer. Although radiological tests provide...

Enfortumab Vedotin Approved for Recurrent Bladder Cancer

Enfortumab Vedotin Approved for Recurrent Bladder Cancer

On December 18, 2019, the Food and Drug Administration (FDA) granted accelerated approval to enfortumab vedotin-ejfv (Padcev) for people with advanced bladder cancer that has...